Answers are grounded in this paper and cite their sources.
Vasodilator therapy with papaverine and/or prostaglandin E1 is associated with lower in-hospital mortality and prevalence of abdominal surgery in patients with nonocclusive mesenteric ischemia.
No takes yet. Share an insight, caveat, or question.
Takiguchi et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: